Progress in the prevention of childhood iron poisoning

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 6, 2005, Pages 593-595

  Woolf, Alan ^a   Litovitz, Toby ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON;

DEATH; DRUG FORMULATION; DRUG PACKAGING; EDITORIAL; EDUCATION; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH PRACTITIONER; HUMAN; IRON OVERLOAD; LIVER NECROSIS; MEDICAL CARE; MORBIDITY; MORTALITY; POISON CENTER; PRENATAL CARE; PRIORITY JOURNAL; SHOCK; CAUSE OF DEATH; CHILD; DIET SUPPLEMENTATION; INTOXICATION; LEGAL ASPECT; METHODOLOGY; NOTE; UNITED STATES;

CAUSE OF DEATH; CHILD; DIETARY SUPPLEMENTS; DRUG PACKAGING; HUMANS; IRON; POISON CONTROL CENTERS; POISONING; UNITED STATES;

EID: 20644458752     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.6.593     Document Type: Editorial

References (9)

1. Title 16 Commercial Practices, Chapter II-Consumer Product Safety Commission, Subchapter E: Poison Prevention Packaging Act of 1970 Regulations. Fed Regist. 1973;38:21247-21250.
2. Rodgers GB. The effectiveness of child-resistant packaging for aspirin. Arch Pediatr Adolesc Med. 2002;156:929-933.
3. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents. Pediatrics. 1992;89:999-1006.
4. Tenenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med. 2005;159:557-560.
5. Morris CC. Pediatric iron poisonings in the United States. South Med J. 2000;93:352-358.
6. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
7. US Consumer Product Safety Commission. Briefing Package: Petition to Amend Child-Resistance Testing Pass/Fail Criterion for Unit Packaging. Washington, DC: US Consumer Product Safety Commission; 2004. PP03-1.
8. Food and Drug Administration; HHS. Iron-containing supplements and drugs; label warning requirements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs (21 CFR Parts 111 and 310; Docket Nos 91P-0186 and 93P-0306). Fed Regist. 2003;68:59714-59715. Available at: www.gpoaccess.gov. Accessed January 6, 2005.
9. Banner W, Woolf AD. Deferoxamine, International Programme on Chemical Safety (IPCS) Evaluation, IPCS INTOX Databank, 2004. Available at: www.intox.org. Accessed January 4, 2005.